Sanderling Ventures is an investment firm from San Mateo, California that specializes in seed and early-stage ventures, as well as late-stage funding. It focuses on emerging biomedical businesses such as in the areas of life sciences, biotechnology, therapeutics, medical devices, drug delivery, pharmaceuticals, medical informatics, health information technology and health care services. It caters to entrepreneurs in the US and Canada. This company was founded in 1979 by Robert McNeil.
Sanderling is among the most seasoned venture firms committed to building new biomedical companies. As of 2019, it has supported over 90 biomedical companies from startups to commercial development, earning high returns on its investments.
ViaCyte is a biotechnology company using stem cells to create pancreatic beta cell precursors for treating diabetes.
SpecificiT Pharma is a biotechnology company developing cancer immunotherapies using stem cells.
Clinical-stage biotechnology company targeting calcium release-activated calcium (CRAC) channels to treatment of inflammatory and autoimmune disorders and organ transplant rejection
Lineagen is a Salt Lake City genetics and diagnostics company providing evaluation services for autism, developmental delay and genetic disorders.
Sotera Wireless is a San Diego-based healthcare company.
PreciThera, Inc. is a biotech company that is positioned to develop therapies for bone diseases.
A company focused on developing therapies for cancer
InfraReDx is a healthcare company.
A company developing antiviral medicines for the treatment of diseases
A company designing bio-therapeutics for endocrine and other disorders
A biopharmaceutical company developing small molecule therapeutics for respiratory, inflammatory and autoimmune diseases
A biotechnology company developing treatments for inflammatory diseases
TORAX Medical is a Shoreview, Minnesota-based healthcare company.
A biopharmaceutical company developing small molecule therapeutics for respiratory and inflammatory disorders
Xytis is a biopharmaceutical company focusing on the discovery and development of CNS drug candidates.
General Counsel & Principal
Peter McWilliams, Ph.D.
Founder & Managing Director
Chief Financial Officer & Principa l
Timothy C. Mills
Managing Director & Head - San Diego Office
Documentaries, videos and podcasts